118 related articles for article (PubMed ID: 9862364)
1. Soluble CD21 induces activation and differentiation of human monocytes through binding to membrane CD23.
Frémeaux-Bacchi V; Aubry JP; Bonnefoy JY; Kazatchkine MD; Kolb JP; Fischer EM
Eur J Immunol; 1998 Dec; 28(12):4268-74. PubMed ID: 9862364
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD21 (sCD21) forms biologically active complexes with CD23: sCD21 is present in normal plasma as a complex with trimeric CD23 and inhibits soluble CD23-induced IgE synthesis by B cells.
Frémeaux-Bacchi V; Fischer E; Lecoanet-Henchoz S; Mani JC; Bonnefoy JY; Kazatchkine MD
Int Immunol; 1998 Oct; 10(10):1459-66. PubMed ID: 9796912
[TBL] [Abstract][Full Text] [Related]
3. The Epstein-Barr virus-binding site on CD21 is involved in CD23 binding and interleukin-4-induced IgE and IgG4 production by human B cells.
Henchoz-Lecoanet S; Jeannin P; Aubry JP; Graber P; Bradshaw CG; Pochon S; Bonnefoy JY
Immunology; 1996 May; 88(1):35-9. PubMed ID: 8707347
[TBL] [Abstract][Full Text] [Related]
4. Pairs of surface molecules involved in human IgE regulation: CD23-CD21 and CD40-CD40L.
Bonnefoy JY; Gauchat JF; Life P; Graber P; Mazzei G; Aubry JP
Eur Respir J Suppl; 1996 Aug; 22():63s-66s. PubMed ID: 8871046
[TBL] [Abstract][Full Text] [Related]
5. Functional properties of soluble CD21.
Frémeaux-Bacchi V; Kolb JP; Rakotobé S; Kazatchkine MD; Fischer EM
Immunopharmacology; 1999 May; 42(1-3):31-7. PubMed ID: 10408363
[TBL] [Abstract][Full Text] [Related]
6. Involvement of Fc epsilon RII/CD23 and L-arginine-dependent pathway in IgE-mediated stimulation of human monocyte functions.
Mossalayi MD; Paul-Eugène N; Ouaaz F; Arock M; Kolb JP; Kilchherr E; Debré P; Dugas B
Int Immunol; 1994 Jul; 6(7):931-4. PubMed ID: 7947461
[TBL] [Abstract][Full Text] [Related]
7. The 25-kDa soluble CD23 activates type III constitutive nitric oxide-synthase activity via CD11b and CD11c expressed by human monocytes.
Aubry JP; Dugas N; Lecoanet-Henchoz S; Ouaaz F; Zhao H; Delfraissy JF; Graber P; Kolb JP; Dugas B; Bonnefoy JY
J Immunol; 1997 Jul; 159(2):614-22. PubMed ID: 9218576
[TBL] [Abstract][Full Text] [Related]
8. Ligation of CD23 activates soluble guanylate cyclase in human monocytes via an L-arginine-dependent mechanism.
Paul-Eugène N; Kolb JP; Sarfati M; Arock M; Ouaaz F; Debré P; Mossalayi DM; Dugas B
J Leukoc Biol; 1995 Jan; 57(1):160-7. PubMed ID: 7829968
[TBL] [Abstract][Full Text] [Related]
9. Purification and characterization of soluble CD21 from human plasma by affinity chromatography and density gradient centrifugation.
Masilamani M; Apell HJ; Illges H
J Immunol Methods; 2002 Dec; 270(1):11-8. PubMed ID: 12379334
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of human IgE production by a subset of anti-CD21 monoclonal antibodies: requirement of a co-signal to modulate epsilon transcripts.
Henchoz S; Gauchat JF; Aubry JP; Graber P; Pochon S; Bonnefoy JY
Immunology; 1994 Feb; 81(2):285-90. PubMed ID: 7512529
[TBL] [Abstract][Full Text] [Related]
11. Low-affinity IgE receptor (FcepsilonRII)-mediated activation of human monocytes by both monomeric IgE and IgE/anti-IgE immune complex.
Ezeamuzie CI; Al-Attiyah R; Shihab PK; Al-Radwan R
Int Immunopharmacol; 2009 Aug; 9(9):1110-4. PubMed ID: 19505590
[TBL] [Abstract][Full Text] [Related]
12. Human lymphocytes shed a soluble form of CD21 (the C3dg/Epstein-Barr virus receptor, CR2) that binds iC3b and CD23.
Frémeaux-Bacchi V; Bernard I; Maillet F; Mani JC; Fontaine M; Bonnefoy JY; Kazatchkine MD; Fischer E
Eur J Immunol; 1996 Jul; 26(7):1497-503. PubMed ID: 8766552
[TBL] [Abstract][Full Text] [Related]
13. Decreased levels of serum soluble complement receptor-II (CR2/CD21) in patients with rheumatoid arthritis.
Masilamani M; von Kempis J; Illges H
Rheumatology (Oxford); 2004 Feb; 43(2):186-90. PubMed ID: 12867574
[TBL] [Abstract][Full Text] [Related]
14. Regulation of IgE synthesis by CD23/CD21 interaction.
Bonnefoy JY; Gauchat JF; Life P; Graber P; Aubry JP; Lecoanet-Henchoz S
Int Arch Allergy Immunol; 1995; 107(1-3):40-2. PubMed ID: 7542093
[TBL] [Abstract][Full Text] [Related]
15. CD23/CD21 interaction is required for presentation of soluble protein antigen by lymphoblastoid B cell lines to specific CD4+ T cell clones.
Grosjean I; Lachaux A; Bella C; Aubry JP; Bonnefoy JY; Kaiserlian D
Eur J Immunol; 1994 Dec; 24(12):2982-6. PubMed ID: 7805725
[TBL] [Abstract][Full Text] [Related]
16. CD21 is a ligand for CD23 and regulates IgE production.
Aubry JP; Pochon S; Graber P; Jansen KU; Bonnefoy JY
Nature; 1992 Aug; 358(6386):505-7. PubMed ID: 1386409
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD21 is developmentally regulated during thymic maturation of human T lymphocytes.
Fischer EM; Mouhoub A; Maillet F; Frémeaux-Bacchi V; Krief C; Gould H; Berrih-Aknin S; Kazatchkine MD
Int Immunol; 1999 Nov; 11(11):1841-9. PubMed ID: 10545488
[TBL] [Abstract][Full Text] [Related]
18. IgE secretion is attenuated by an inhibitor of proteolytic processing of CD23 (Fc epsilonRII).
Christie G; Barton A; Bolognese B; Buckle DR; Cook RM; Hansbury MJ; Harper GP; Marshall LA; McCord ME; Moulder K; Murdock PR; Seal SM; Spackman VM; Weston BJ; Mayer RJ
Eur J Immunol; 1997 Dec; 27(12):3228-35. PubMed ID: 9464810
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus binding to CD21, the virus receptor, activates resting B cells via an intracellular pathway that is linked to B cell infection.
Roberts ML; Luxembourg AT; Cooper NR
J Gen Virol; 1996 Dec; 77 ( Pt 12)():3077-85. PubMed ID: 9000100
[TBL] [Abstract][Full Text] [Related]
20. Decreased levels of sCD21 and sCD23 in blood of patients with systemic-juvenile arthritis, polyarticular-juvenile arthritis, and pauciarticular-juvenile arthritis.
Singh A; Vastert SJ; Prakken BJ; Illges H
Rheumatol Int; 2012 Jun; 32(6):1581-7. PubMed ID: 21328056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
